Keyphrases
Meta-analysis of Randomized Controlled Trials
100%
C-reactive Protein
100%
C-reactive Protein Level
100%
Lipid-lowering Therapy
100%
Comprehensive Meta-analysis
100%
Placebo
40%
Randomized Controlled Trial
40%
Protein Concentration
40%
Statins
40%
LDL Cholesterol
40%
Ezetimibe
40%
Bempedoic Acid
40%
Inflammation
20%
Regression Analysis
20%
Drug Class
20%
Meta-analysis
20%
Between-group
20%
Triglycerides
20%
Confidence Interval
20%
Inclusion Criteria
20%
English Language
20%
Lipid-lowering Drugs
20%
Anti-inflammatory Effect
20%
Inflammatory Biomarkers
20%
PRISMA Guidelines
20%
Omega-3 Fatty Acids
20%
Cholesterol Reduction
20%
Serum C-reactive Protein
20%
Atherosclerotic Cardiovascular Disease (ASCVD)
20%
Cardiovascular Prevention
20%
Group Treatment
20%
Fibrates
20%
Cholesterol Absorption Inhibitor
20%
Proprotein Convertase Subtilisin/kexin Type 9 Inhibitors
20%
Intervention Duration
20%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
C Reactive Protein
100%
Inflammation
22%
Placebo
22%
Low Density Lipoprotein Cholesterol
22%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
22%
Ezetimibe
22%
Bempedoic Acid
22%
Biological Marker
11%
Triacylglycerol
11%
Coronary Artery Atherosclerosis
11%
Antilipemic Agent
11%
Antiinflammatory Activity
11%
Fibric Acid Derivative
11%
Omega-3 Fatty Acid
11%
Cholesterol Ester Transfer Protein Inhibitor
11%
Proprotein Convertase 9
11%